MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Ovarian cancer is a leading cause of cancer-related deaths in women.
• Aberrant expression of microRNA-214 (miR-214) and semaphorin 4D (sema 4D) is implicated in various cancers.
• Understanding the roles of miR-214 and sema 4D in ovarian cancer is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the cellular function of miR-214 in ovarian cancer.
• To determine the regulatory relationship between miR-214 and sema 4D.
• To validate sema 4D as a direct target of miR-214 in ovarian cancer cells.

Main Methods:

• Quantitative real-time PCR and Western blotting to assess miR-214 and sema 4D expression levels.
• Cell proliferation assays and apoptosis assays in SKOV-3 cells with altered miR-214 expression.
• Bioinformatic analysis to predict miR-214 binding sites on sema 4D mRNA.
• Luciferase reporter assays to confirm direct targeting of sema 4D by miR-214.

Main Results:

• miR-214 expression was significantly lower in ovarian cancer tissues and cells compared to normal controls.
• Overexpression of miR-214 inhibited SKOV-3 cell proliferation and induced apoptosis, suggesting a tumor-suppressive role.
• Sema 4D expression was upregulated in ovarian cancer tissues and cells.
• miR-214 directly targeted the 3'-untranslated region of sema 4D mRNA, suppressing its expression at both nucleic acid and protein levels.

Conclusions:

• miR-214 functions as a tumor suppressor in ovarian cancer.
• miR-214 negatively regulates sema 4D expression by directly binding to its mRNA.
• The miR-214/sema 4D axis represents a potential therapeutic target for ovarian cancer treatment.